News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chung Jane
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Chung Jane (Chief Commercial Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Paid exercise price by delivering 6,483 shares
@ $4.22, valued at
$27.4k
Exercised 18,750 restricted stock units
@ $0 |
|
| 06/09/2023 |
4
| Chung Jane (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 03/07/2023 |
4
| Chung Jane (Chief Commercial Officer) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Paid exercise price by delivering 3,211 shares
@ $5.79, valued at
$18.6k
Granted 40,000 options to buy
@ $5.79, valued at
$231.6k
Granted 27,500 restricted stock units
@ $0
Exercised 7,875 restricted stock units
@ $0 |
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|